Clinical Trial Update: Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating irinotecan use in metastatic or recurrent colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED